Quarter Period Consolidated Statement Of Comprehensive Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7728785

Concept 2017-04-01 to
2017-12-31
2016-04-01 to
2016-12-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
16,859,000,000 JPY
17,983,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,288,000,000 JPY
469,000,000 JPY
Remeasurements of defined benefit plans, net of tax
333,000,000 JPY
329,000,000 JPY
Other comprehensive income
1,621,000,000 JPY
798,000,000 JPY
Comprehensive income
18,481,000,000 JPY
18,782,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
18,481,000,000 JPY
18,782,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.